CSRC allows for simplified review procedures for offering shares to purchase assets / CLP Reference: 3700/25.05.16 ; Promulgated: 2025-05-16 ; Effective: 2025-05-16
Legal
- June 30, 2025
The intersection between intellectual property and artificial intelligence raises challenging and significant legal issues. Danlei Wu of Fangda Partners examines China’s first case relating to the structure and parameters of an AI model
June 30, 2025U.S. to tighten disclosure obligations of foreign listed companies, targeting China; China to allow local investors to invest more in overseas assets under QDII; and EU issues measures to restrict Chinese medical device manufacturers from accessing public procurement contracts
June 26, 2025SAMR issues rules to implement the safe harbor system concerning monopoly agreements. CSRC allows for simplified review procedures for offering shares to purchase assets. Trust companies are exempted from setting up supervisory boards.
June 20, 2025SPC defines “same kind of good or service” in criminal IP cases / CLP Reference: 5100/25.04.23 ; Promulgated: 2025-04-23 ; Effective: 2025-04-26
June 20, 2025Western companies concerned about China's demand for sensitive rare earths information; Irish data regulators target transparency and transfer impact assessment failures in landmark decision; and China's largest insurer plans to raise HK$11.77 billion through convertible bond listing in Frankfurt
June 19, 2025CEO and General Counsel of MyoMed Bio, explains how legal strategy—spanning IP, regulatory compliance, and cross-border structuring—is essential for enabling clinical development, managing geopolitical and data protection risks, and aligning biotech operations across China, the U.S., and Australia.
June 17, 2025Chinese regulator scrutinizes Apple’s AI rollout with Alibaba amid trade war; the Trump administration plans to extend restrictions to cover subsidiaries of sanctioned tech companies; and China announces scheme to convert confiscated cryptocurrency into cash
June 12, 2025Xiangxiang Ma, a partner of Anjie Broad Law Firm, explores the various ways in which a recent U.S. executive order on drug pricing is impacting Chinese pharmaceutical companies’ license-out model
June 06, 2025Chinese EV giant BYD investigated in U.S. for alleged ties to Chinese Communist Party; European companies more pessimistic about doing business in China amid economic slowdown; and the world’s first intergovernmental legal organization for mediation established in Hong Kong
June 05, 2025







